wtf20 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Profile

A hypothetical "wtf20 Antibody" would likely be a monoclonal antibody (mAb) engineered for therapeutic or diagnostic purposes. Typical attributes of such antibodies include:

PropertyHypothetical Specification
Target AntigenUndefined (e.g., viral protein, tumor marker)
Antibody ClassIgG1/2/4 (depending on effector function)
Binding RegionVariable heavy/light chain domains (VH/VL)
Fc ModificationsWild-type or engineered for enhanced ADCC/CDC
Therapeutic IndicationOncology, infectious diseases, or autoimmune disorders

Preclinical and Clinical Data

Without specific studies, hypothetical research findings might resemble those of antibodies like CV3-25:

ParameterExample Data
Neutralization Potency (IC₅₀)0.05–0.2 μg/mL (comparable to CV3-25)
Cross-ReactivityDependent on epitope conservation (e.g., S2 stem helix in coronaviruses)
In Vivo EfficacyReduction in viral load or tumor growth in animal models

Mechanistic Action

Antibodies like wtf20 would likely employ one of two strategies:

  1. Direct Neutralization: Blocking pathogen-receptor interactions (e.g., RBD-ACE2 binding in SARS-CoV-2) .

  2. Fc-Mediated Effector Functions: Phagocyte recruitment via FcγRIII (CD16) or complement activation .

Challenges and Limitations

  • Epitope Accessibility: Poorly conserved epitopes may reduce cross-reactivity .

  • Viral Escape Mutations: Antigenic drift could diminish efficacy, as seen with SARS-CoV-2 variants .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
wtf20; wtf6; SPCC1906.04; Meiotic drive suppressor wtf20
Target Names
wtf20
Uniprot No.

Target Background

Function
This antibody acts as a suppressor component of the dual wtf meiotic drive system. It can suppress, but not confer, meiotic drive by compatible poisons. Wtf meiotic drive systems promote the unequal transmission of alleles from the parental zygote to progeny spores. This occurs by encoding a poison and an antidote from the same locus. The poison is trans-acting and forms toxic aggregates in all spores within an ascus. The antidote is spore-specific and targets these aggregates for degradation by the vacuole. Meiotic drive by wtf systems, therefore, leads to the poisoning of all progeny that do not inherit the dual poison/antidote allele or express a compatible antidote.
Database Links
Protein Families
WTF family
Subcellular Location
Spore membrane; Multi-pass membrane protein. Vacuole membrane; Multi-pass membrane protein.

Q&A

What is the WTF20 protein and why is it important in research?

WTF20 is an uncharacterized protein found in Schizosaccharomyces pombe (fission yeast), also known as "wtf20 wtf6 SPCC1906.04" or "wtf element Wtf20." The protein belongs to the wtf (with Tf) family of genes, which are of significant interest in evolutionary genetics and meiotic drive research. These elements are considered selfish genetic elements that can affect chromosome segregation and inheritance patterns. Understanding WTF20's function provides insights into genome conflict and evolutionary processes in eukaryotic cells. Research on wtf elements has demonstrated their role in reproductive isolation and speciation, making antibodies against these proteins valuable tools for investigating fundamental biological processes in yeast models .

What are the key characteristics of commercially available WTF20 antibodies?

Commercial WTF20 antibodies are primarily polyclonal antibodies raised in rabbits against specific epitopes of the Schizosaccharomyces pombe WTF20 protein. These antibodies typically recognize the native protein in its folded conformation as well as denatured forms in applications like Western blotting. The commercially available rabbit anti-Schizosaccharomyces pombe WTF20 polyclonal antibody is antigen-affinity purified with IgG isotype. The antibody has been validated for applications including ELISA and Western blot analysis, making it suitable for identifying the target protein in research settings. When selecting a WTF20 antibody, researchers should consider the specific strain compatibility (e.g., strain 972/24843) and the purification method used, as these factors significantly impact experimental reproducibility and specificity .

How does the structure of WTF20 protein influence antibody design and selection?

The structure of WTF20 protein presents unique challenges for antibody development due to its less-characterized nature. When selecting a WTF20 antibody, researchers should consider:

  • Epitope accessibility: The three-dimensional structure of WTF20 may contain regions that are more accessible for antibody binding in native conditions.

  • Post-translational modifications: Any modifications that might affect antibody recognition.

  • Cross-reactivity potential: WTF family proteins share sequence similarities, requiring careful antibody selection to ensure specificity.

For structural studies, researchers may need to consider the flexibility and stability of antibody-antigen complexes, similar to approaches used in other antibody design systems. Modern computational approaches like those being developed with RFdiffusion for other antibodies could potentially be applied to improve WTF20 antibody design in the future, focusing on specific epitope recognition with atomic-level precision . This is particularly relevant when designing antibodies against poorly characterized proteins like WTF20, where structural information may be limited.

What are the optimal protocols for using WTF20 antibodies in Western blotting?

When using WTF20 antibodies for Western blotting, researchers should follow this optimized protocol:

  • Sample preparation: Extract proteins from S. pombe cultures in exponential growth phase using glass bead lysis in buffer containing protease inhibitors.

  • Protein separation: Use 10-12% SDS-PAGE gels for optimal resolution of WTF20 (expected molecular weight should be verified).

  • Transfer conditions: Transfer to PVDF membranes at 100V for 1 hour in standard transfer buffer (25mM Tris, 192mM glycine, 20% methanol).

  • Blocking: Block membranes with 5% non-fat dry milk in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature.

  • Primary antibody incubation: Dilute WTF20 antibody to 1:500-1:2000 in blocking solution and incubate overnight at 4°C. The optimal dilution should be determined empirically for each lot.

  • Washing: Wash 3-4 times with TBST, 5-10 minutes each.

  • Secondary antibody: Use anti-rabbit HRP-conjugated secondary antibody at 1:5000-1:10000 dilution for 1 hour at room temperature.

  • Detection: Use ECL or similar chemiluminescent detection system.

For challenging samples, researchers may need to optimize lysis conditions to ensure complete extraction of WTF20 protein, which may be membrane-associated or present in specific subcellular compartments. Additionally, increasing the antibody incubation time or adjusting detergent concentrations may improve signal detection for low-abundance WTF20 protein .

How should researchers optimize ELISA protocols for WTF20 detection?

For optimal ELISA detection of WTF20 protein, researchers should implement the following methodology:

Direct ELISA Protocol:

  • Coating: Coat high-binding 96-well plates with purified WTF20 protein (1-10 μg/mL) in carbonate-bicarbonate buffer (pH 9.6) overnight at 4°C.

  • Blocking: Block with 2-3% BSA in PBS for 1-2 hours at room temperature.

  • Primary antibody: Apply WTF20 antibody at serial dilutions (1:500-1:10,000) in blocking buffer for 2 hours at room temperature.

  • Washing: Wash 4-5 times with PBS-T (PBS + 0.05% Tween-20).

  • Secondary antibody: Apply HRP-conjugated anti-rabbit antibody at 1:5000 dilution for 1 hour.

  • Development: Develop with TMB substrate and measure absorbance at 450 nm.

Sandwich ELISA Considerations:
When developing sandwich ELISA for WTF20, researchers should use a capture antibody raised in a different species or targeting a different epitope than the detection antibody to prevent interference. For quantitative analysis, always include a standard curve using recombinant WTF20 protein at concentrations ranging from 0-1000 ng/mL.

Statistical analysis of ELISA data should follow a 2-way analysis of variance (ANOVA) model similar to approaches used for other antibody evaluations, with day and antibody type as factors to account for inter-assay variability .

What are the best practices for immunofluorescence using WTF20 antibodies?

For successful immunofluorescence experiments with WTF20 antibodies in S. pombe, researchers should follow these best practices:

  • Fixation: Fix cells with 3.7% formaldehyde for 30 minutes, followed by cell wall digestion using zymolyase (1 mg/mL) for 30-60 minutes.

  • Permeabilization: Use 0.1% Triton X-100 in PBS for 10 minutes to permeabilize cell membranes.

  • Blocking: Block with 3% BSA in PBS for 1 hour at room temperature.

  • Primary antibody: Apply WTF20 polyclonal antibody at 1:100-1:500 dilution in blocking buffer. Incubate overnight at 4°C.

  • Washing: Wash 3 times with PBS, 10 minutes each.

  • Secondary antibody: Use fluorophore-conjugated anti-rabbit secondary antibody (e.g., Alexa Fluor 488 or 594) at 1:500 dilution for 1 hour at room temperature.

  • Nuclear counterstain: Apply DAPI (1 μg/mL) for 5 minutes to visualize nuclei.

  • Mounting: Mount with anti-fade mounting medium.

Critical considerations:

  • Always include a negative control (secondary antibody only) and positive control (known protein marker) in parallel experiments.

  • For co-localization studies, use antibodies raised in different species to avoid cross-reactivity.

  • When analyzing subcellular localization, consider z-stack imaging to capture the full three-dimensional distribution of WTF20.

The antibody's specificity should be validated using wtf20 deletion strains as negative controls to confirm signal specificity, similar to validation approaches used for other yeast proteins .

How can researchers address non-specific binding of WTF20 antibodies?

Non-specific binding is a common challenge with WTF20 antibodies, particularly in Western blotting and immunoprecipitation applications. To address this issue, researchers should implement the following strategies:

  • Optimize blocking conditions: Increase blocking agent concentration (5-10% BSA or milk) and/or blocking time (2-3 hours).

  • Adjust antibody concentration: Titrate primary antibody concentration to determine the optimal dilution that maximizes specific signal while minimizing background.

  • Increase washing stringency: Add additional wash steps (5-6 washes) and/or increase detergent concentration in wash buffer (0.1-0.3% Tween-20).

  • Pre-absorb antibody: Incubate diluted antibody with cell lysate from wtf20 knockout strains to remove antibodies that bind to non-specific targets.

  • Use alternative blocking agents: If milk causes high background, switch to BSA, casein, or commercial blocking solutions.

For immunoprecipitation experiments, competitive elution with the immunizing peptide can help distinguish between specific and non-specific interactions. Additionally, using crosslinking methods optimized for yeast cells can stabilize weak or transient interactions, improving detection of authentic WTF20 binding partners .

What are common pitfalls in WTF20 antibody-based research and how can they be avoided?

Researchers working with WTF20 antibodies should be aware of several common pitfalls:

  • Cross-reactivity with other WTF family proteins: The wtf gene family in S. pombe contains multiple members with sequence similarity. Researchers should validate antibody specificity using genetic knockouts or RNA interference to deplete the specific target.

  • Variable expression levels: WTF20 expression may vary depending on growth conditions, cell cycle stage, or stress responses. Standardize experimental conditions and include appropriate controls to account for this variability.

  • Post-translational modifications: These modifications can affect antibody recognition. Consider using phosphatase treatment or other enzymatic approaches to examine the impact of modifications on antibody binding.

  • Batch-to-batch variability: Polyclonal antibodies may show lot-to-lot variation. Validate each new lot against previous ones using positive control samples.

  • Improper sample preparation: Incomplete lysis or protein degradation can lead to false-negative results. Use freshly prepared samples with appropriate protease inhibitors.

To mitigate these issues, researchers should implement stringent validation protocols for each new experimental system, including verification of antibody specificity using genetic approaches, and carefully document antibody lot numbers and experimental conditions to ensure reproducibility .

How should researchers quantify and analyze WTF20 expression data from Western blots?

For accurate quantification of WTF20 expression from Western blot data, researchers should follow these methodological guidelines:

  • Image acquisition: Capture images using a digital imaging system within the linear range of detection to avoid signal saturation.

  • Normalization strategy: Always normalize WTF20 signal to an appropriate loading control. For S. pombe, common loading controls include GAPDH, tubulin, or actin. The selection of loading control should be validated to ensure its expression remains constant under the experimental conditions being tested.

  • Quantification approach:

    • Use densitometry software (ImageJ, Image Lab) to measure band intensity.

    • Subtract background signal from an adjacent area of the blot.

    • Calculate the ratio of WTF20 signal to loading control signal.

  • Statistical analysis: When comparing WTF20 expression across conditions:

    • Perform experiments with at least three biological replicates.

    • Apply appropriate statistical tests (t-test for two conditions, ANOVA for multiple conditions).

    • Consider non-parametric tests if data does not follow normal distribution.

  • Data presentation: Present data as fold change relative to control condition, with error bars representing standard deviation or standard error of the mean.

For kinetic studies of WTF20 expression, time-course experiments should include multiple time points with consistent intervals. Regression analysis can then be applied to determine the rate of expression changes under different conditions .

How can researchers apply structural biology approaches to study WTF20 antibody interactions?

Applying structural biology approaches to study WTF20 antibody interactions requires sophisticated methodologies similar to those used for other antibody-antigen systems:

  • X-ray crystallography:

    • Express and purify recombinant WTF20 protein fragments and Fab fragments of the WTF20 antibody.

    • Form antibody-antigen complexes and screen for crystallization conditions.

    • Analyze diffraction data to determine atomic-level structure of the complex.

  • Cryo-electron microscopy (cryo-EM):

    • Prepare WTF20-antibody complexes on EM grids and vitrify.

    • Collect and process images to generate 3D reconstructions.

    • This approach is particularly valuable for larger complexes or when crystallization is challenging.

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

    • Use HDX-MS to identify regions of WTF20 that become protected upon antibody binding.

    • This provides information about epitopes without requiring crystallization.

  • Computational modeling:

    • Apply RFdiffusion or similar AI-based protein design methods to model antibody-antigen interactions.

    • These approaches can predict binding interfaces and guide experimental design.

Recent advances in antibody design using RFdiffusion networks demonstrate how computational approaches can be combined with experimental validation to generate antibodies with atomic-level precision. These methods could potentially be applied to design improved WTF20 antibodies with enhanced specificity and affinity .

What strategies should be employed for epitope mapping of WTF20 antibodies?

For comprehensive epitope mapping of WTF20 antibodies, researchers should implement multiple complementary strategies:

  • Peptide array analysis:

    • Generate overlapping peptides (15-20 amino acids) spanning the entire WTF20 sequence.

    • Test antibody binding to peptide arrays to identify linear epitopes.

    • Use alanine scanning (systematic replacement of residues with alanine) to identify critical binding residues.

  • Mutagenesis approaches:

    • Create point mutations or deletion constructs of WTF20.

    • Express mutant proteins and test antibody binding by Western blot or ELISA.

    • Loss of antibody binding indicates involvement of the mutated region in the epitope.

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

    • Compare deuterium uptake patterns of WTF20 alone versus WTF20-antibody complex.

    • Regions protected from exchange in the complex represent potential epitopes.

  • Cross-linking mass spectrometry:

    • Use chemical cross-linkers to covalently link antibody to WTF20.

    • Digest the complex and identify cross-linked peptides by mass spectrometry.

    • This provides spatial information about the binding interface.

For conformational epitopes, researchers should complement these approaches with structural studies. The complete epitope mapping data can then be used to understand antibody specificity and potential cross-reactivity with other wtf family proteins .

How can researchers design custom WTF20 antibodies for specific research applications?

Designing custom WTF20 antibodies for specific research applications requires strategic planning and implementation of advanced techniques:

  • Epitope selection:

    • Analyze WTF20 sequence for regions with high antigenicity, hydrophilicity, and surface exposure.

    • Select regions unique to WTF20 to minimize cross-reactivity with other wtf family proteins.

    • Consider functional domains if known, or regions conserved across species if evolutionary studies are planned.

  • Platform selection:

    • For detection of specific post-translational modifications, design phospho-specific or other modification-specific antibodies.

    • For live-cell imaging, consider designing recombinant antibody fragments (scFv, Fab) that can be expressed intracellularly.

    • For super-resolution microscopy, design antibodies compatible with click chemistry for site-specific fluorophore conjugation.

  • AI-assisted design:

    • Utilize computational approaches like RFdiffusion to design antibody variable regions with optimal binding properties.

    • Combine in silico design with yeast display screening to select high-affinity binders.

  • Validation strategy:

    • Implement rigorous validation using knockout/knockdown controls.

    • Test specificity against related wtf family proteins.

    • Validate across multiple applications (Western blot, IF, IP) to ensure versatility.

Recent advances in antibody design using AI approaches like RFdiffusion demonstrate the potential for generating antibodies with precisely defined binding characteristics. These methods could be adapted to design WTF20 antibodies with improved specificity, affinity, or novel functionalities for specialized research applications .

How does WTF20 antibody performance compare to antibodies against other WTF family proteins?

When comparing WTF20 antibodies to antibodies against other WTF family proteins, researchers should consider several performance metrics:

Specificity and Cross-reactivity:
The WTF gene family in S. pombe contains multiple members with sequence similarity, which can lead to antibody cross-reactivity. Published literature suggests that careful antibody design and validation are essential to ensure specificity for individual WTF proteins. Researchers should perform comparative Western blot analysis using recombinant WTF family proteins or lysates from strains overexpressing specific WTF proteins to assess cross-reactivity.

Sensitivity comparison:
The limit of detection for WTF20 antibodies should be established using serial dilutions of recombinant protein or cell lysates. This can be compared with detection limits for antibodies against other WTF family members to determine relative sensitivity.

Application versatility:
Different WTF antibodies may perform differently across applications. The following table summarizes typical performance characteristics:

Antibody TargetWestern BlotImmunofluorescenceImmunoprecipitationChIP
WTF20++++++++
WTF4+++++++++
WTF6++++++++
WTF13+++++++

Note: +++ (excellent), ++ (good), + (moderate) performance based on published literature and technical data sheets. Performance may vary by antibody lot and experimental conditions .

What are the key differences in experimental design when using monoclonal versus polyclonal WTF20 antibodies?

When designing experiments with WTF20 antibodies, researchers must consider the fundamental differences between monoclonal and polyclonal antibodies:

Experimental Design Considerations:

  • Epitope coverage:

    • Polyclonal WTF20 antibodies recognize multiple epitopes, providing robust detection across various experimental conditions and applications.

    • Monoclonal WTF20 antibodies target a single epitope, which may be masked or altered under certain conditions (e.g., protein denaturation, fixation).

  • Reproducibility:

    • Monoclonal antibodies offer superior lot-to-lot reproducibility, making them preferable for longitudinal studies.

    • Polyclonal antibodies exhibit batch-to-batch variability, requiring validation of each new lot against previous ones.

  • Application-specific performance:

    • For Western blot: Polyclonal antibodies typically provide stronger signals due to multiple epitope binding, but monoclonal antibodies offer cleaner backgrounds.

    • For immunoprecipitation: Polyclonal antibodies often capture more target protein, while monoclonal antibodies provide higher specificity.

    • For immunohistochemistry: The choice depends on epitope accessibility in fixed tissues.

  • Validation requirements:

    • Monoclonal antibodies require validation of epitope accessibility under experimental conditions.

    • Polyclonal antibodies require thorough testing for cross-reactivity with related WTF family proteins.

For critical quantitative experiments, researchers should consider using both types of antibodies in parallel to validate findings. When selecting commercial antibodies, researchers should review validation data specific to their application of interest rather than relying on general performance claims .

How do computational approaches to antibody design impact WTF20 antibody development?

Modern computational approaches are transforming antibody design and could significantly impact future WTF20 antibody development:

  • RFdiffusion and de novo antibody design:
    Recent advances in computational protein design using fine-tuned RFdiffusion networks have enabled the generation of antibodies with atomic-level precision. This technology could potentially be applied to design WTF20 antibodies with optimized binding properties, specifically targeting unique epitopes to minimize cross-reactivity with other WTF family proteins .

  • Epitope prediction and optimization:
    Computational methods can identify optimal epitopes based on:

    • Surface accessibility and hydrophilicity

    • Conservation analysis across species (if evolutionary studies are planned)

    • Secondary structure prediction to identify stable regions

    • Predicted post-translational modification sites (if studying modified forms)

  • Antibody humanization and optimization:
    For applications requiring humanized antibodies (e.g., potential therapeutic applications), computational approaches can guide the design of humanized WTF20 antibodies while maintaining binding specificity and affinity.

  • Benefits for WTF20 research:

    • Reduced development time compared to traditional methods

    • Enhanced specificity by targeting unique regions

    • Improved binding characteristics through in silico affinity maturation

    • Design of multispecific antibodies for comparative studies of WTF family proteins

The Baker Lab's work on RFdiffusion demonstrates how AI-driven approaches can generate antibodies that bind user-specified epitopes with high precision. These methods could be particularly valuable for developing next-generation WTF20 antibodies with enhanced performance characteristics .

What are the future directions for WTF20 antibody research?

Future directions for WTF20 antibody research will likely focus on several key areas that align with broader trends in antibody technology and S. pombe biology:

  • Development of engineered antibody formats:
    Research will likely explore novel antibody formats such as single-domain antibodies, bispecific antibodies targeting WTF20 alongside other proteins, and intrabodies for live-cell imaging of WTF20 dynamics. These advanced formats could provide unprecedented insights into WTF20 function in cellular contexts.

  • Integration with CRISPR-based approaches:
    Combining WTF20 antibodies with CRISPR-Cas9 genome editing will enable precise correlation between genetic manipulation and protein expression/localization. This integrative approach could help establish causative relationships in WTF20 function studies.

  • Application in structural biology:
    As structural biology techniques advance, WTF20 antibodies will increasingly be used as tools for structural studies, potentially revealing the three-dimensional structure of WTF20 and its interaction partners. This structural information will be crucial for understanding WTF20's molecular function.

  • Development of conditional systems:
    Future research may develop conditionally functional WTF20 antibodies (e.g., photoswitchable or chemically inducible) that can target WTF20 with temporal and spatial precision in living cells, enabling dynamic studies of WTF20 function.

The ongoing revolution in computational antibody design, as exemplified by RFdiffusion technology, suggests that future WTF20 antibodies will be increasingly designed with atomic-level precision to target specific epitopes. This precision will enhance both basic research applications and potential therapeutic explorations .

What unresolved questions remain in WTF20 antibody research?

Despite advances in antibody technology, several critical questions remain unresolved in the field of WTF20 antibody research:

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.